Obama and the Safety of our Blood Supply
By Eileen F. Toplansky in American Thinker
Each day another damning detail emerges about President
Obama's deliberate assault on every facet of America's institutions and the
potentially dire effects on Americans. With the burgeoning host of
diseases now entering the U.S., courtesy of Barack Hussein Obama, what impact
does this onslaught have on the blood supply and its quality? Let's
consider the witch’s brew now facing America's health care system.
Judicial Watch uncovered
Obama's stealth operation to "actively formulate plans to admit
Ebola-infected non-U.S. citizens into the United States for treatment within
the first days of diagnosis." Yet it is "unclear who would bear the
high costs of transporting and treating non-citizen Ebola patients." In
fact, "the plans include special waivers of laws and regulations that ban
the admission of non-citizens with a communicable disease as dangerous as
Ebola."
Bryan Preston notes that
the Morbidity and Mortality Weekly Report or MMWR, "is the Centers for
Disease Control's premiere journal for reporting and tracking infectious
diseases in the United States." And, yet, the MMWR for the week
ending October 4, 2014 made no mention of the Ebola case in Dallas.
Puzzling, indeed, since Ebola is a viral hemorrhagic fever and the CDC
specifically lists it as a notifiable disease in a 2010 report.
And as we have come to expect from the least transparent
administration, the "Obama administration has shunned multiple requests
to respond to the report exposing its secret plan to admit Ebola infected
foreigners into the United States."
Then there are the illegals coming from
Mexico, Honduras, Guatemala and El Salvador with their myriad collection of
diseases, many of which have not been encountered in this country. Dengue
fever occurs in Central and South America and has led to 1/2 million
hospitalizations and 25,000 deaths. According to Winton Gibbons in his
article entitled "Blood Screening/Transfusion Future Product Market
Concepts" of September 2013, "[o]nly 13% of low income countries have
a national hemovigilance system to monitor and improve safe blood
transfusion."
Which brings me to
Dengue fever. Dengue is endemic in more than 110 countries.
According to a June 2011 article entitled "Dengue
antibodies in blood donors," the authors conclude that "the results
of the current analysis show that the introduction of quantitative or molecular
serological methods to determine the presence of anti-dengue antibodies or the
detection of the dengue virus in blood donors...should be established so that
the quality of blood transfusions is guaranteed." And while the authors
assert that "the current research suggests that blood donors were not
actively infected with the dengue virus...it is well known that methodologies
for virus detection also include the more efficient viral RNA and NSI antigen
investigations for the dengue virus which eliminate the immunological window
period. The current study may not have identified anti-dengue IgM
antibodies [.]" It should be noted that while a testing kit has been
produced that can identify Dengue within 15
minutes at an 80 percent success rate, there is no vaccine available for Dengue
Fever.
The World Health
Organization (WHO) in a March 2014 fact sheet maintains that
"over 2.5 billion people -- over 40% of the world's population -- are now
at risk from dengue." In fact, "explosive outbreaks are
occurring" with France, Croatia and the Madeira islands of Portugal
experiencing the disease.
In 2013, cases
occurred in Florida. Notably, Honduras, Costa Rica and Mexico are also
afflicted. Dengue is spread by the Aedes aegypti mosquito, and
"infected humans are the main carriers and multipliers of the virus,
serving as a source of the virus for uninfected mosquitoes." In the
case of severe dengue "medical care by physicians and nurses experienced
[italics mine] with the effects and progression of the disease can save
lives."
In a 2009 article
entitled "Dengue virus antibodies in blood donors from an endemic area" the
authors state that "the main transmission route seems to be by mosquito
vector; nevertheless, transmission by needle stick injuries, bone marrow
transplantation and intrapartum vertical transmission have been
reported." Moreover, recent reports have demonstrated dengue viremia
in blood donors from Honduras, Brazil, Australia and Puerto Rico, which are
endemic areas for dengue infection. In addition, transmission ... by
blood transfusion had been recently documented in two recipients from
Singapore." Thus, the authors assert that "[t]echnically, it is
possible for Dengue Fever Virus or DENV to be transmitted through blood
transfusions [.]" It would not take much for certain mosquitoes
already common in the US. to bite infected
individuals and spread these viruses.
And while genuine
fears of Ebola contamination exist for U.S. troops in the Hot Zone, the
"deployment of U.S. troops to areas of the world where mosquito-borne
diseases are endemic, and increased travel to and from those areas, has raised
concern that these diseases could inadvertently be brought to the U.S. and
spread through transmitting mosquitoes already existing in this country.
Thus, these viruses pose a potential threat to the nation's blood supply."
In addition to the
South and Central American onslaught of illegals, "there is Obama's
decision to allow thousands of Haitians into the United States without
visas. Douglas Ernst explains that the
Obama administration plans "to allow as many as 100,000 Haitians to
immigrate to the U.S. without a visa." This has Sen. Chuck Grassley
asserting that this is "an irresponsible overreach of the executive
branch's authority." Furthermore, Grassley maintains that the number
of Haitians would "likely exceed that estimate" since it is
"just the beginning of the president's unilateral and executive actions on
immigration." Moreover, some 5 percent of Haiti, or over 500,000
people came down with cholera during the last
outbreak. As a result, "Haiti even exported its cholera to ... Cuba
and Venezuela. Actually, "an outbreak of cholera has
been ongoing in Haiti since October 2010 according to an August 4, 2014 update
from the CDC and "cases continue to be reported." Daniel
Greenfield reports that "cholera used to be rare in the United States, but
increased under Obama after an upswing in Haiti and the Dominican
Republic."
Increasing people's
unease is the information that on August 1, 2014, the FDA published an updated
guidance for industry entitled "Recommendations for Donor Questioning,
Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted
Malaria." These recommendations stated that
Blood establishments
using the abbreviated DHQ (aDHQ) are urged to read Section VI.B. carefully. FDA
has provided instructions that the question “In the past three years have you
been outside the United States or Canada?”
The FDA instructions
further state that for the one year this is ongoing, there are options for use
of the malaria evaluation information on the flowchart corresponding to the
aDHQ question “Since your last donation, have you been outside the United
States or Canada?” No matter which option a facility chooses, the question that
has been placed in the “Additional Questions” section must be used with each
donor. Even if the donor is evaluated for malaria risks using the “Since your
last donation have you been outside the US or Canada?” question and is deferred
for 12 months, the donor must be screened again; the new flowchart may
determine that the donor should be deferred for a longer period.
Then there is
chikungunya, another mosquito transmitted disease which began in late 2013 in
the Caribbean and has infected thousands of people. In fact, "[t]he
clinical manifestations of chikungunya fever resemble those of dengue
fever. [Thus] laboratory diagnosis is critical to establish the cause of
diagnosis."
In a 2009 article
entitled "Chikungunya Virus: Possible Impact on Transfusion Medicine," the authors
acknowledge that
Estimated transfusion
risks range as high as 150 per 10,000 donations during outbreaks. Possible
measures to prevent possible CHIKV transfusion transmission include deferral of
symptomatic donors, discontinuing blood collections in affected areas, and
CHIKV nucleic acid screening of donations. Even a relatively small outbreak in
Italy resulted in [a] considerable adverse impact on blood collections and
economic consequence.
There is "no
specific treatment or vaccine." At Transfusion News, a Dr.
Katz states that:
We’ve seen literally hundreds of thousands
and probably millions of cases in the Indian Ocean and South Asia without
documented transfusion-transmission. Same thing in the Caribbean, there’s no
recognized transfusion-transmission in the Caribbean, but we know that the
virus is in the blood and we know it can be transmitted parenterally in a
Macaque primate model, so I think it’s very plausible that
transfusion-transmission could occur.”
There are no current standards on donor
deferral periods during a chikungunya outbreak, donor screening questions, or
licensed screening tests. Since the outbreak is likely to spread, however, the
transfusion community needs to be prepared.
An individual who donated blood in Haiti
notes that
Chikungunya fever, an acute, mosquito-borne,
viral illness, first appeared in Haiti in April, 2014. Many Haitians and
ex-pats have already had chikungunya. Someone who is acutely ill with
chikungunya fever (or any acute febrile illness or other significant illness)
obviously cannot donate blood [.] Since the chikungunya outbreak started, I
have donated blood twice in Haiti (at 2 different blood donation sites), and I
was not asked any specific questions about chikungunya either time.
As if this were not enough, there is Chagas disease which is
caused by the blood-borne parasite Trypanosoma cruzi. In her
1994 book entitled The Coming Plague: Newly Emerging Diseases
in a World Out of Balance," author Laurie Garrett documents how the Chagas'
disease organism "found a more direct way to infect people: bypassing the
insect vector, the protozoa entered the blood-bank systems." It affects
an estimated 11 million persons throughout much of Latin America. In an MMWR
Weekly dated February 23, 2007, one learns that
. . . one study revealed an increasing Chagas
seroprevalence among blood donors in Los Angeles County, California, from 1996
(one in 9,850 donors) to 1998 (one in 5,400 donors). In 1991, a questionnaire
was introduced to screen blood donors; those reporting a history of Chagas
disease are deferred, but most persons with Chagas disease likely are unaware
of their infections. Seven cases of transfusion-associated transmission have
been documented in the United States and Canada during the past 20 years; all
occurred in immunosuppressed recipients. Because acute infections often are
asymptomatic and the level of awareness of Chagas disease among clinicians is
low, cases of transfusion-associated transmission can go undetected.
But in 2005, a new commercial test for blood-donation
screening for Chagas disease was developed. Yet, in this 2010 article, one learns that "the test is
not yet mandatory, but many facilities have already begun screening all blood
donors for this disease."
Nonetheless, we have to take into account that the daily
living routines and habits of people coming from these Chagas affected regions
will take many years to offset and change. And it should be understood
that the illegals today are not the immigrants of yester-year. Many are
not here to become Americans and work hard to make the American dream a
reality. They are here because of government handouts promised by Obama
et al.
What is the likelihood of illegals being truthful about
their medical history? What will be the costs to Americans to do all this
testing on these people as they increasingly require medical care? Laurie
Garrett reminds the reader that during the AIDS crisis, "[b]lood bank
administrators gave lip service publicly to concerns about blood supply safety,
but privately told government authorities that no steps could be taken to
ensure product safety without incurring prohibitive costs." What of
the exorbitant costs that all these illegals will incur? Viruses mutate,
science is not static -- what new genetic changes will occur that will impede
successful identification and treatment? Many questions, few answers and
no confidence in an administration that continually lies to the American
public.
And speaking of health care, in addition to these
lingering questions, consider that the Obama administration "has
dragged its feet on revoking Obamacare coverage
for people who can’t prove U.S. citizenship or legal residency, allowing some
of the estimated 11 million illegal immigrants in the U.S. to continue enjoying
taxpayer-funded benefits."
So as illegals flood in from the world, health care
declines for all American citizens of any racial background. As hospitals
are overwhelmed with more people and more diseases, how will the blood banks
deal with the need for more blood transfusions? How safe is the blood
bank? Should certain people, like illegal aliens, foreigners,
and people with a history of addiction or a criminal record, be denied a place
on waiting lists for organ donations? Who receives priority?
Black residents in Chicago are
calling Obama the "worst president ever, [as] he [chooses] illegals over
Americans."
Thus, "[t]he Obama administration is bending over
backwards to give Obamacare to illegal immigrants but won’t protect hardworking
American citizens who are losing their health care coverage,” according to Sen.
David Vitter.
But not to worry - after the November 2014 elections,
Obama, with his pen and his phone, is preparing to grant de facto citizenship
to millions of illegals by giving them green cards.
Voila! You are an American. You broke the law;
Congress was ignored; the will of the American people was patently disregarded;
diseases that doctors have not seen for years have now sprung up in our
schools; and the financial burden on the American taxpayer will be onerous, but
this is the Obama way.
So while "incompetence meets mendacity in Obama
administration's Ebola response", the final coup de grace is the
possibility of "detecting bioterror attacks by
screening blood donors: a best case analysis." This August 2003
piece queries whether screening blood donors could provide early warning of a
bioterror attack. The author shows that
. . . imperfect test specificity could
overwhelm the blood collection system with false-positive results. In addition,
the costs of screening apply to all blood donations tested: even if the cost of
screening were as low as an incremental $10 per test, screening all blood
donations in the United States to detect a bioterror attack would cost an
additional $139 million per year at current donation rates. Total costs would
be even higher when the resources that would be expended investigating
false-positive results are considered. For all of these reasons, blood donors
should not be screened for bioterror agents for the purpose of detecting a
bioterror attack.
Then what better way to do irreparable harm to America
than with one suicide bioterrorist!
When chaos is called for, Obama is at the top of his
game. It is neither incompetence nor an oversight -- these actions are as
Obama did promise -- a transformation of the country into an overwhelmed,
dependent and increasingly less free land.
Obama continues his lawless moves to (a) increase
potential Democrat voters (b) devastate the country's resources (c) actively
and knowingly put Americans at risk (d) bring America down to size for its
racist past, (d) and ultimately create a situation where only the government
can "save" the country via more and more control. Marx and
Alinsky would be proud.
Eileen can be reached at middlemarch18@gmail.com
Each day another damning detail emerges about President
Obama's deliberate assault on every facet of America's institutions and the
potentially dire effects on Americans. With the burgeoning host of
diseases now entering the U.S., courtesy of Barack Hussein Obama, what impact
does this onslaught have on the blood supply and its quality? Let's
consider the witch’s brew now facing America's health care system.
Judicial Watch uncovered
Obama's stealth operation to "actively formulate plans to admit
Ebola-infected non-U.S. citizens into the United States for treatment within
the first days of diagnosis." Yet it is "unclear who would bear the
high costs of transporting and treating non-citizen Ebola patients." In
fact, "the plans include special waivers of laws and regulations that ban
the admission of non-citizens with a communicable disease as dangerous as
Ebola."
Bryan Preston notes that
the Morbidity and Mortality Weekly Report or MMWR, "is the Centers for
Disease Control's premiere journal for reporting and tracking infectious
diseases in the United States." And, yet, the MMWR for the week
ending October 4, 2014 made no mention of the Ebola case in Dallas.
Puzzling, indeed, since Ebola is a viral hemorrhagic fever and the CDC
specifically lists it as a notifiable disease in a 2010 report.
And as we have come to expect from the least transparent
administration, the "Obama administration has shunned multiple requests
to respond to the report exposing its secret plan to admit Ebola infected
foreigners into the United States."
Then
there are the illegals coming from
Mexico, Honduras, Guatemala and El Salvador with their myriad collection of
diseases, many of which have not been encountered in this country. Dengue
fever occurs in Central and South America and has led to 1/2 million
hospitalizations and 25,000 deaths. According to Winton Gibbons in his
article entitled "Blood Screening/Transfusion Future Product Market
Concepts" of September 2013, "[o]nly 13% of low income countries have
a national hemovigilance system to monitor and improve safe blood
transfusion."
Which brings me to
Dengue fever. Dengue is endemic in more than 110 countries.
According to a June 2011 article entitled
"Dengue antibodies in blood donors," the authors conclude that
"the results of the current analysis show that the introduction of
quantitative or molecular serological methods to determine the presence of
anti-dengue antibodies or the detection of the dengue virus in blood
donors...should be established so that the quality of blood transfusions is
guaranteed." And while the authors assert that "the current research
suggests that blood donors were not actively infected with the dengue virus...it
is well known that methodologies for virus detection also include the more
efficient viral RNA and NSI antigen investigations for the dengue virus which
eliminate the immunological window period. The current study may not have
identified anti-dengue IgM antibodies [.]" It should be noted that
while a testing kit has been produced that can identify Dengue within 15
minutes at an 80 percent success rate, there is no vaccine available for Dengue
Fever.
The World Health
Organization (WHO) in a March 2014 fact sheet maintains that
"over 2.5 billion people -- over 40% of the world's population -- are now
at risk from dengue." In fact, "explosive outbreaks are
occurring" with France, Croatia and the Madeira islands of Portugal
experiencing the disease.
In 2013, cases
occurred in Florida. Notably, Honduras, Costa Rica and Mexico are also
afflicted. Dengue is spread by the Aedes aegypti mosquito, and
"infected humans are the main carriers and multipliers of the virus,
serving as a source of the virus for uninfected mosquitoes." In the
case of severe dengue "medical care by physicians and nurses experienced
[italics mine] with the effects and progression of the disease can save
lives."
In a 2009 article
entitled "Dengue virus antibodies in blood donors from an endemic area" the
authors state that "the main transmission route seems to be by mosquito
vector; nevertheless, transmission by needle stick injuries, bone marrow
transplantation and intrapartum vertical transmission have been
reported." Moreover, recent reports have demonstrated dengue viremia
in blood donors from Honduras, Brazil, Australia and Puerto Rico, which are
endemic areas for dengue infection. In addition, transmission ... by
blood transfusion had been recently documented in two recipients from
Singapore." Thus, the authors assert that "[t]echnically, it is
possible for Dengue Fever Virus or DENV to be transmitted through blood
transfusions [.]" It would not take much for certain mosquitoes
already common in the US. to bite infected
individuals and spread these viruses.
And while genuine
fears of Ebola contamination exist for U.S. troops in the Hot Zone, the
"deployment of U.S. troops to areas of the world where mosquito-borne
diseases are endemic, and increased travel to and from those areas, has raised
concern that these diseases could inadvertently be brought to the U.S. and
spread through transmitting mosquitoes already existing in this country.
Thus, these viruses pose a potential threat to the nation's blood supply."
In addition to the
South and Central American onslaught of illegals, "there is Obama's
decision to allow thousands of Haitians into the United States without
visas. Douglas Ernst explains that the
Obama administration plans "to allow as many as 100,000 Haitians to
immigrate to the U.S. without a visa." This has Sen. Chuck Grassley
asserting that this is "an irresponsible overreach of the executive
branch's authority." Furthermore, Grassley maintains that the number
of Haitians would "likely exceed that estimate" since it is
"just the beginning of the president's unilateral and executive actions on
immigration." Moreover, some 5 percent of Haiti, or over 500,000
people came down with cholera during the last
outbreak. As a result, "Haiti even exported its cholera to ... Cuba
and Venezuela. Actually, "an outbreak of cholera has
been ongoing in Haiti since October 2010 according to an August 4, 2014 update
from the CDC and "cases continue to be reported." Daniel
Greenfield reports that "cholera used to be rare in the United States, but
increased under Obama after an upswing in Haiti and the Dominican
Republic."
Increasing people's
unease is the information that on August 1, 2014, the FDA published an updated
guidance for industry entitled "Recommendations for Donor Questioning,
Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted
Malaria." These recommendations stated that
Blood establishments
using the abbreviated DHQ (aDHQ) are urged to read Section VI.B. carefully. FDA
has provided instructions that the question “In the past three years have you
been outside the United States or Canada?”
The FDA instructions
further state that for the one year this is ongoing, there are options for use
of the malaria evaluation information on the flowchart corresponding to the
aDHQ question “Since your last donation, have you been outside the United
States or Canada?” No matter which option a facility chooses, the question that
has been placed in the “Additional Questions” section must be used with each
donor. Even if the donor is evaluated for malaria risks using the “Since your
last donation have you been outside the US or Canada?” question and is deferred
for 12 months, the donor must be screened again; the new flowchart may
determine that the donor should be deferred for a longer period.
Then there is
chikungunya, another mosquito transmitted disease which began in late 2013 in
the Caribbean and has infected thousands of people. In fact, "[t]he
clinical manifestations of chikungunya fever resemble those of dengue
fever. [Thus] laboratory diagnosis is critical to establish the cause of
diagnosis."
In a 2009 article
entitled "Chikungunya Virus: Possible Impact on Transfusion Medicine," the authors
acknowledge that
Estimated transfusion
risks range as high as 150 per 10,000 donations during outbreaks. Possible
measures to prevent possible CHIKV transfusion transmission include deferral of
symptomatic donors, discontinuing blood collections in affected areas, and
CHIKV nucleic acid screening of donations. Even a relatively small outbreak in
Italy resulted in [a] considerable adverse impact on blood collections and
economic consequence.
There is "no
specific treatment or vaccine." At Transfusion News, a Dr.
Katz states that:
We’ve seen literally hundreds of thousands
and probably millions of cases in the Indian Ocean and South Asia without
documented transfusion-transmission. Same thing in the Caribbean, there’s no
recognized transfusion-transmission in the Caribbean, but we know that the
virus is in the blood and we know it can be transmitted parenterally in a
Macaque primate model, so I think it’s very plausible that
transfusion-transmission could occur.”
There are no current standards on donor
deferral periods during a chikungunya outbreak, donor screening questions, or
licensed screening tests. Since the outbreak is likely to spread, however, the
transfusion community needs to be prepared.
An individual who donated blood in Haiti
notes that
Chikungunya fever, an acute, mosquito-borne,
viral illness, first appeared in Haiti in April, 2014. Many Haitians and
ex-pats have already had chikungunya. Someone who is acutely ill with
chikungunya fever (or any acute febrile illness or other significant illness)
obviously cannot donate blood [.] Since the chikungunya outbreak started, I
have donated blood twice in Haiti (at 2 different blood donation sites), and I
was not asked any specific questions about chikungunya either time.
As if this were not enough, there is Chagas disease which is
caused by the blood-borne parasite Trypanosoma cruzi. In her
1994 book entitled The Coming Plague: Newly Emerging Diseases
in a World Out of Balance," author Laurie Garrett documents how the Chagas'
disease organism "found a more direct way to infect people: bypassing the
insect vector, the protozoa entered the blood-bank systems." It
affects an estimated 11 million persons throughout much of Latin America. In an
MMWR Weekly dated February 23, 2007, one learns that
. . . one study revealed an increasing Chagas
seroprevalence among blood donors in Los Angeles County, California, from 1996
(one in 9,850 donors) to 1998 (one in 5,400 donors). In 1991, a questionnaire
was introduced to screen blood donors; those reporting a history of Chagas
disease are deferred, but most persons with Chagas disease likely are unaware
of their infections. Seven cases of transfusion-associated transmission have
been documented in the United States and Canada during the past 20 years; all
occurred in immunosuppressed recipients. Because acute infections often are
asymptomatic and the level of awareness of Chagas disease among clinicians is
low, cases of transfusion-associated transmission can go undetected.
But in 2005, a new commercial test for blood-donation
screening for Chagas disease was developed. Yet, in this 2010 article, one learns that "the test is
not yet mandatory, but many facilities have already begun screening all blood
donors for this disease."
Nonetheless, we have to take into account that the daily
living routines and habits of people coming from these Chagas affected regions
will take many years to offset and change. And it should be understood
that the illegals today are not the immigrants of yester-year. Many are
not here to become Americans and work hard to make the American dream a
reality. They are here because of government handouts promised by Obama
et al.
What is the likelihood of illegals being truthful about
their medical history? What will be the costs to Americans to do all this
testing on these people as they increasingly require medical care? Laurie
Garrett reminds the reader that during the AIDS crisis, "[b]lood bank
administrators gave lip service publicly to concerns about blood supply safety,
but privately told government authorities that no steps could be taken to
ensure product safety without incurring prohibitive costs." What of
the exorbitant costs that all these illegals will incur? Viruses mutate,
science is not static -- what new genetic changes will occur that will impede
successful identification and treatment? Many questions, few answers and
no confidence in an administration that continually lies to the American
public.
And speaking of health care, in addition to these
lingering questions, consider that the Obama administration "has
dragged its feet on revoking Obamacare coverage
for people who can’t prove U.S. citizenship or legal residency, allowing some
of the estimated 11 million illegal immigrants in the U.S. to continue enjoying
taxpayer-funded benefits."
So as illegals flood in from the world, health care
declines for all American citizens of any racial background. As hospitals
are overwhelmed with more people and more diseases, how will the blood banks
deal with the need for more blood transfusions? How safe is the blood
bank? Should certain people, like illegal aliens, foreigners,
and people with a history of addiction or a criminal record, be denied a place
on waiting lists for organ donations? Who receives priority?
Black residents in Chicago are
calling Obama the "worst president ever, [as] he [chooses] illegals over
Americans."
Thus, "[t]he Obama administration is bending over
backwards to give Obamacare to illegal immigrants but won’t protect hardworking
American citizens who are losing their health care coverage,” according to Sen.
David Vitter.
But not to worry - after the November 2014 elections,
Obama, with his pen and his phone, is preparing to grant de facto citizenship
to millions of illegals by giving them green cards.
Voila! You are an American. You broke the law;
Congress was ignored; the will of the American people was patently disregarded;
diseases that doctors have not seen for years have now sprung up in our
schools; and the financial burden on the American taxpayer will be onerous, but
this is the Obama way.
So while "incompetence meets mendacity in Obama
administration's Ebola response", the final coup de grace is the
possibility of "detecting bioterror attacks by
screening blood donors: a best case analysis." This August 2003
piece queries whether screening blood donors could provide early warning of a
bioterror attack. The author shows that
. . . imperfect test specificity could
overwhelm the blood collection system with false-positive results. In addition,
the costs of screening apply to all blood donations tested: even if the cost of
screening were as low as an incremental $10 per test, screening all blood
donations in the United States to detect a bioterror attack would cost an
additional $139 million per year at current donation rates. Total costs would
be even higher when the resources that would be expended investigating
false-positive results are considered. For all of these reasons, blood donors
should not be screened for bioterror agents for the purpose of detecting a
bioterror attack.
Then what better way to do irreparable harm to America
than with one suicide bioterrorist!
When chaos is called for, Obama is at the top of his
game. It is neither incompetence nor an oversight -- these actions are as
Obama did promise -- a transformation of the country into an overwhelmed,
dependent and increasingly less free land.
Obama continues his lawless moves to (a) increase
potential Democrat voters (b) devastate the country's resources (c) actively
and knowingly put Americans at risk (d) bring America down to size for its
racist past, (d) and ultimately create a situation where only the government
can "save" the country via more and more control. Marx and
Alinsky would be proud.
No comments:
Post a Comment